In PNAS this week: pan-cancer analysis of Fbw7 mutations, COBASI approach to find single-nucleotide variants, and more.
Smithsonian reports that some researchers are turning to gene editing to target established infections like herpes.
The institute is being funded with a gift from the family of recently deceased Costco Cofounder Jeff Brotman, and will be directed by UW's Jay Shendure.
The company combines screening of live, patient-derived tumor cells with DNA sequencing and data analysis to match individuals with optimal drug therapies.
The assay combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis to match patients with drug therapies.
Oncoscape, an open-source data tool developed at Fred Hutchinson Cancer Research Center, will soon be able to produce 3D exome visualizations on commercial VR headsets.
The virus spread according to a gravity model between large population centers, and its movements were affected by geographical distance.
The two new single-cell RNA-sequencing methods aim to overcome some of the limitations of single-cell transcriptomics.
A modified version of a commercially available magnetic bead cell sorting instrument from Miltenyi Biotec could be deployed to areas without cGMP facilities.
In Genome Research this week: Sus scrofa genetic variants, translational plasticity might minimize effects of harmful mutations, and more.
A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.
Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.
A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.
In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more